Alumis (ALMS) Change in Acquisitions & Divestments (2023 - 2025)
Alumis' (ALMS) quarterly Change in Acquisitions & Divestments came in at $142.5 million in Q4 2025, up 65.73% year-on-year from $86.0 million in Q4 2024, and down 11.55% on a QoQ basis from $161.1 million in Q3 2025.
Alumis (ALMS) Change in Acquisitions & Divestments (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $142.5 million in Q4 2025.
- On a quarterly basis, Change in Acquisitions & Divestments rose 65.73% year-over-year to $142.5 million in Q4 2025; TTM through Dec 2025 was $448.0 million, a 249.96% increase from a year earlier, with the FY2025 full-year figure at $448.0 million, up 249.96% from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 stood at $142.5 million, down from $161.1 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for ALMS reached as high as $161.1 million in Q3 2025 and fell as low as $1.0 million in Q1 2024.
- Historically, Change in Acquisitions & Divestments has averaged $65.1 million across 3 years, with a median of $64.0 million in 2025.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 6300.0% in 2025 and fell as far as 65.73% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $9.8 million in 2023, then surged by 782.05% to $86.0 million in 2024, then jumped by 65.73% to $142.5 million in 2025.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $142.5 million in Q4 2025, $161.1 million in Q3 2025, and $80.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Alumis | 2.30 Bn | 1.99 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 142.53 Mn |
| Dec 31, 2025 | 142.53 Mn |
| Sep 30, 2025 | 161.15 Mn |
| Sep 30, 2025 | 161.15 Mn |
| Jun 30, 2025 | 80.27 Mn |
| Jun 30, 2025 | 80.27 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | 86.00 Mn |
| Dec 31, 2024 | 86.00 Mn |
| Sep 30, 2024 | 34.00 Mn |
| Sep 30, 2024 | 34.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Sep 30, 2023 | 9.75 Mn |
| Sep 30, 2023 | 9.75 Mn |